- $550.76m
- $152.50m
- $424.63m
Annual income statement for Mestek, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 305 | 299 | 417 | 398 | 425 |
| Cost of Revenue | |||||
| Gross Profit | 91.5 | 90.6 | 125 | 132 | 145 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 283 | 280 | 367 | 323 | 308 |
| Operating Profit | 21.7 | 19.6 | 50.1 | 75.4 | 117 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 21.4 | 20.1 | 51.9 | 79.8 | 120 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12.8 | 12.5 | 37.1 | 59.4 | 87.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 8.68 | 12.5 | 37 | 59.4 | 87.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 8.68 | 12.5 | 37 | 59.4 | 87.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.87 | 1.73 | 4.9 | 7.87 | 11.6 |
| Dividends per Share | |||||
| Special Dividends per Share |